Pharma Nord

What Pharma Nord does

Pharma Nord is a Danish pharmaceutical-grade nutraceutical company founded in 1981 by Eli Wallin and Sven Moesgaard, headquartered in Vejle, Denmark, with GMP-certified manufacturing operations in Vojens. The company develops, produces, and markets dietary supplements and registered medicines with an emphasis on high bioavailability, safety, and scientific documentation, serving health-conscious consumers, healthcare professionals, and individuals with documented nutritional deficiencies across more than 40 countries through 25 wholly-owned subsidiaries and 20 cooperation partners. The company is privately held under continued founder ownership as Pharma Nord ApS (CVR 67 30 30 16), a member of Food Supplements Europe (FSE), and a recipient of multiple regional industry awards between 2007 and 2026.

The product portfolio centers on essential nutrients including coenzyme Q10 (in both ubiquinone and ubiquinol forms, sold as both registered medicines and dietary supplements), selenium (SelenoPrecise yeast), magnesium, calcium combined with vitamins D and K, and broad-spectrum multivitamins. Pharma Nord's technical differentiation rests on several proprietary technologies: a patented Q10 crystal heat-treatment process (EP 3 191 444 B1) that ensures complete dissolution at body temperature; SelenoPrecise organic selenium yeast with documented 89% absorption; Phytocaps cellulose-free vegetable capsules developed by wholly-owned subsidiary Precise Ingredients; and an oxygen-purged oil matrix technology that protects active ingredients from oxidation. All products are manufactured under pharmaceutical GMP standards at the Vojens facility, supported by a research database of more than 10,000 scientific studies and over 300 published studies conducted on Pharma Nord's own preparations, including landmark trials such as Q-Symbio and KiSel-10.

Pharma Nord's commercial model combines direct-to-consumer e-commerce (country-specific webshops including a flexible subscription/delivery service) with B2B distribution through pharmacies and health food stores where trained personnel advise customers. Revenue is generated primarily through one-time product sales of dietary supplements, with secondary streams from registered medicines (notably Bio-Qinon Q10 30 mg, the only Q10 medicine in Denmark indicated for prevention and treatment of Q10 deficiency) and professional education events (Masterclass programs for healthcare practitioners). The company's intellectual property portfolio includes multiple trademarked brands (Bio-Quinone, SelenoPrecise, ChromoPrecise, Uniqinol, Phytocaps) that anchor its identity as a research-driven, premium-positioned nutraceutical producer with a Bio-Quinone Q10 product serving as the official reference for the International Coenzyme Q10 Association (ICQA).

Name

Pharma Nord

Legal name

Pharma Nord ApS

Website

https://pharmanord.dk

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

251–500 employees

Short description

Pharma Nord is a Danish nutraceutical company founded in 1981 that develops, manufactures, and markets dietary supplements and registered medicines under pharmaceutical GMP standards, serving health-conscious consumers and healthcare professionals across 40+ countries through subsidiaries and pharmacy distribution channels.

Ownership category

akta.pro rank

Product category

Dietary Supplements and Preventive Medicines

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Food (Health) Supplement Retailers (456191)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE)

akta.pro secondary industries

Multivitamins & Daily Packs (CRADAGAC), Healthy Aging & Cognitive Support Supplements (CRADAGAM), Vitamins & Minerals (Single Nutrients) (CRADAGAB)

Keywords

• Dietary supplements
• Preventive medicines
• Nutritional supplements
• Coenzyme Q10 products
• Pharmaceutical manufacturing

Headquarters

HQ city

Vejle

HQ country

Denmark

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Direct-to-Consumer Dietary Supplements Sales: Pharma Nord generates revenue through consumer e-commerce sales of dietary supplements via their webshop (pharmanord.dk and shop.pharmanord.eu for international markets). Products include Q10 formulations, minerals (magnesium, calcium), multivitamins, and other nutritional supplements sold directly to health-conscious consumers.
2. Prescription and OTC Medicines: Revenue from registered medicines including Bio-Qinon Q10 30mg, which is the only Q10 medicine in Denmark indicated for prevention and treatment of Q10 deficiency. Medicines are sold through pharmacies with prescription or OTC depending on market regulations.
3. B2B Professional Channel Sales: Distribution through pharmacies and health food stores where trained professional staff provides customer advice. The company emphasizes that their products are sold in stores where consumers can receive guidance from qualified personnel.
4. Subscription/Delivery Service: Pharma Nord offers a subscription delivery service where products are delivered at fixed intervals. No binding commitment; customers can cancel, modify content, or adjust shipping frequency at any time. Changes take effect immediately.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Pharma Nord develops, manufactures, and markets dietary supplements and preventive medicines with emphasis on high bioavailability, safety, and scientific documentation. The company operates a GMP-certified production facility in Vojens, Denmark producing tablet and capsule preparations, and sells a portfolio spanning Coenzyme Q10 (in both ubiquinone and ubiquinol forms, including a registered pharmaceutical), selenium (SelenoPrecise), magnesium, calcium with vitamins D and K, and broad-spectrum multivitamins to consumers in 40+ countries.

Product overview

Pharma Nord develops, manufactures, and markets dietary supplements and preventive medicines with a focus on high bioavailability, safety, and scientific documentation. The product portfolio centers on essential nutrients including coenzyme Q10 (in both ubiquinone and ubiquinol forms, as both medicine and supplement), selenium (SelenoPrecise), magnesium, calcium with vitamins D and K, and broad-spectrum multivitamins. Q10 products span four distinct offerings: the registered preventive medicine Bio-Qinon Q10 30 mg (the only Q10 medicine in Denmark), the flagship dietary supplement Bio-Quinone Aktivt Q10 Gold 100 mg (the world's most widely used Q10 brand and ICQA reference product), BioActive Q10 Uniqinol 50 mg (reduced ubiquinol form for those with impaired absorption), and Q10 Phyto 100 mg (vegetarian/vegan Phytocaps version). Supporting mineral and vitamin products include Bio-Magnesium (with sixfold documented blood magnesium elevation), Bio-Calcium+D3+K1+K2 (chewable bone-health formulation), and Multivitamin Pharma Nord (with patented SelenoPrecise selenium). All products, both medicines and supplements, are manufactured under the same pharmaceutical GMP standard at the company's facility in Vojens, Denmark, with over 400 published scientific studies on the product range.

Differentiator

Problem solved

Functional benefit

Brands

• Bio-Quinone Q10: Pharma Nord's flagship Q10 product line — includes Bio-Qinon Q10 (30 mg, pharmaceutical drug), Bio-Quinone Aktivt Q10 Gold (100 mg, dietary supplement), and Q10 Phyto (100 mg, vegan/vegetarian capsule). Reference product for the International Coenzyme Q10 Association (ICQA).
• SelenoPrecise
• Bio-Magnesium
• Bio-Calcium+D3+K1+K2
• Multivitamin Pharma Nord
• Phytocaps
• BioActive Uniqinol

Products and services

• Bio-Qinon Q10 30 mg Registered preventive medicine in capsule form containing 30 mg coenzyme Q10 (ubiquinone) dissolved in vegetable oil via a proprietary heat-treatment process. Indicated for prevention and treatment of coenzyme Q10 deficiency; the only Q10 medicine in Denmark.
• Bio-Quinone Aktivt Q10 Gold 100 mg Dietary supplement containing 100 mg coenzyme Q10 (ubiquinone) per soft gelatin capsule, dissolved in vegetable oil using the patented heat-treatment process (EP 3 191 444 B1) for superior bioavailability. Identical formulation to the research product Myoqinon, tested in over 76 published studies including Q-Symbio and KiSel-10. Reference product for ICQA.
• BioActive Q10 Uniqinol 50 mg Dietary supplement providing 50 mg coenzyme Q10 in its reduced form (ubiquinol) dissolved in coconut oil with added vitamin C. Uses specialized encapsulation technique to keep ubiquinol in its reduced form. Targeted at consumers, particularly older individuals, who may have impaired Q10 absorption from the intestine.
• Q10 Phyto, Bio-Quinone 100 mg Vegetarian/vegan dietary supplement delivering 100 mg ubiquinone Q10 in 100% plant-based Phytocaps capsules made from corn, potato, and pea (cellulose-free). Uses the same patented manufacturing process as Bio-Quinone Q10 Gold, ensuring comparable high bioavailability for vegetarian and vegan consumers.
• Bio-Magnesium Dietary supplement containing a complex of three different magnesium salts (magnesium carbonate, magnesium hydroxide, and magnesium acetate) in a fast-dissolving matrix providing 200 mg elemental magnesium per tablet. Documented in clinical study showing sixfold increase in blood magnesium levels after eight weeks. Suitable for vegetarians and vegans.
• Bio-Calcium+D3+K1+K2 Chewable dietary supplement combining calcium (1000 mg per 2 tablets), vitamin D3, vitamin K1, and vitamin K2 in peppermint-flavored tablets. Formulated to support normal bone and teeth maintenance, normal muscle function, and normal blood clotting. Designed to be combined with Bio-Magnesium for synergistic bone health support.
• Multivitamin Pharma Nord Broad-spectrum dietary supplement containing 12 vitamins and 6 minerals in a single oval tablet manufactured under pharmaceutical control. Includes patented SelenoPrecise selenium yeast with documented stable bioavailability of 88.7% per batch, a full B-complex, vitamin C, E, D, zinc, magnesium, and chromium. Does not contain iron. Suitable for vegetarians.

Quantifiable outcome

• Six-fold increase in blood magnesium levels after 8 weeks of Bio-Magnesium supplementation vs. placebo
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Food Supplements Europe (FSE)coreOthersPharma Nord is a member of Food Supplements Europe (FSE), the European industry association that provides leading expertise and insight in food safety, toxicology, and safety assessments to political stakeholders, industry, and consumers. FSE builds relationships with authorities on food legislation focusing on dietary supplement ingredients, herbs, pre- and pro-biotics as well as vitamins and minerals.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Solgar: Premium vitamin and supplement brand with similar science-based positioning, broad specialty-condition product range (including CoQ10), and global distribution through health-food retail — directly comparable to Pharma Nord's category, GTM, and premium positioning.
• Doctor's Best: Science-positioned supplement brand that also leads with branded ingredients and clinical evidence on CoQ10 and other condition-specific supplements — overlaps directly with Pharma Nord's evidence-based specialty-condition playbook.
• Life Extension: Science-driven supplement company emphasizing clinical research, healthy-aging formulations, and condition-targeted products (including CoQ10 and selenium) — closely comparable to Pharma Nord's research-heavy, premium-positioned model.
• Nordic Naturals: Nordic-origin premium supplement brand (omega-3s and condition-specific products) with international distribution and science-based branding — directly comparable geography, channel mix, and evidence-led marketing.
• BioGaia: Swedish probiotic/health supplement company with patented probiotic strains, strong clinical documentation, and global distribution — directly comparable in Nordic origin, science-led positioning, and patented-ingredient strategy.
• New Chapter / Enzymatic Therapy (Procter & Gamble): Whole-food and condition-specific supplement brand focused on herbal and prenatal supplementation with a science/heritage positioning — closely comparable in specialty-condition range and premium-natural branding.

Broad incumbents

• Now Foods: Large US-headquartered supplement manufacturer with broad SKU range, international distribution, and GMP manufacturing — a broader incumbent that overlaps with Pharma Nord across most categories but at a wider, more price-competitive positioning.
• Nature's Bounty (Nestlé Health Science): Mass-market vitamin and supplement brand owned by a major CPG parent — overlaps with Pharma Nord's product categories and global presence, but competes primarily through scale and distribution rather than scientific differentiation.
• PharmaVite (Nature Made): Manufacturer of the Nature Made supplement brand; GMP-certified producer of condition-specific vitamins and minerals sold through mass retail — directly analogous in operating model and category focus, but at a broader incumbent scale.
• GNC Holdings: Established global supplement retailer and manufacturer with a broad portfolio of condition-specific vitamins and minerals — a broader incumbent that overlaps with Pharma Nord's categories and channels (retail + DTC).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@pharmanord_dk
• LinkedInlinkedin.com/company/pharma-nord
• Facebookfacebook.com/pharmanord.dk

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma Nord